Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4364357 | 4144599 | I | 4364357-2 | 20040513 | 20040525 | EXP | PHNU2004DE01846 | NOVARTIS PHARMACEUTICALS CORP. | 6 | YR | M | Y | 20040525 | OT |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4364357 | 1004888160 | PS | METHYLPHENIDATE HCL | 1 | ORAL | UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4364357 | 1004888160 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4364357 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4364357 | CEREBRAL ARTERY OCCLUSION |
| 4364357 | CEREBRAL INFARCTION |
| 4364357 | DYSARTHRIA |
| 4364357 | FACIAL PARESIS |
| 4364357 | MONOPARESIS |
| 4364357 | VITH NERVE PARALYSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4364357 | 1004888160 | 60480 |